To our knowledge, no patients with DUOX2 and ANO1 variants were described in the literature, but considering the role of ANO1 in thyrocytes, variants in its gene may contribute in the CH patients’ phenotype. This evidence concerns the gene DUOX2 and cyclic hematopoiesis.